BioCentury
ARTICLE | Company News

Scolr Pharma management update

September 7, 2009 7:00 AM UTC

Scolr Pharma Inc. (NYSE-A:DDD), Bothell, Wash. Business: Drug delivery Promoted: Stephen Turner to president and CEO from VP and CTO; he replaces Bruce Morra, who is becoming a director ...